{
    "eid": "2-s2.0-85152253023",
    "title": "Development of SARS-CoV-2 neutralizing antibody detection assay by using recombinant plant-produced proteins",
    "cover-date": "2023-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Biotechnology",
            "@code": "1305",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Applied Microbiology and Biotechnology",
            "@code": "2402",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "COVID-19",
        "Diagnostic reagents",
        "Plant-produced ACE2 protein",
        "SARS-CoV-2",
        "Surrogate virus neutralization"
    ],
    "authors": [
        "Perawat Jirarojwattana",
        "Balamurugan Shanmugaraj",
        "Kaewta Rattanapisit",
        "Waranyoo Phoolcharoen"
    ],
    "citedby-count": 1,
    "ref-count": 42,
    "ref-list": [
        "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor",
        "Covid-19 breakthrough infections in vaccinated health care workers",
        "Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies",
        "Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays",
        "Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2",
        "A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2\u2013spike protein\u2013protein interaction",
        "Plant molecular farming: a viable platform for recombinant biopharmaceutical production",
        "Nicotiana benthamiana as a production platform for artemisinin precursors",
        "Monoclonal antibodies B38 and H4 produced in Nicotiana benthamiana neutralize SARS-CoV-2 in vitro",
        "Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana",
        "Functional characterization of pembrolizumab produced in Nicotiana benthamiana using a rapid transient expression system",
        "Molecular farming on rescue of pharma industry for next generations",
        "Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: protective efficacy, immunogenicity, safety, and toxicity",
        "Immunogenicity and efficacy of recombinant subunit SARS-CoV-2 vaccine candidate in the Syrian hamster model",
        "High-yield production of chimeric hepatitis E virus-like particles bearing the M2e influenza epitope and receptor binding domain of SARS-CoV-2 in plants using viral vectors",
        "Efficacy of a plant-produced clade 2.3.4.4 H5 influenza virus-like particle vaccine in layer hens",
        "Transient expression of Flavivirus structural proteins in Nicotiana benthamiana",
        "Development of a novel assay based on plant-produced infectious bursal disease virus VP3 for the differentiation of infected from vaccinated animals",
        "Transient expression of dengue virus NS1 antigen in Nicotiana benthamiana for use as a diagnostic antigen",
        "Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis",
        "Usefulness of ELISA using total antibody against plant-expressed recombinant nucleocapsid protein of SARS-CoV-2",
        "Plant-produced receptor-binding domain of SARS-CoV-2 elicits potent neutralizing responses in mice and non-human primates",
        "Modifying the replication of geminiviral vectors reduces cell death and enhances expression of biopharmaceutical proteins in Nicotiana benthamiana leaves",
        "Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants",
        "A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2",
        "Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody",
        "Infectious disease threats in the twenty-first century: strengthening the global response",
        "A serological assay to detect SARS-CoV-2 seroconversion in humans",
        "Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test",
        "A new SARS-CoV-2 dual-purpose serology test: highly accurate infection tracing and neutralizing antibody response detection",
        "Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)",
        "Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2",
        "Performance evaluation of four surrogate virus neutralization tests (sVNTs) in comparison to the in vivo gold standard test",
        "Evaluation of a SARS-CoV-2 surrogate virus neutralization test for detection of antibody in human, canine, cat, and hamster sera",
        "Evaluation of neutralizing antibodies against SARS-CoV-2 variants after infection and vaccination using a multiplexed surrogate virus neutralization test"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "117011815",
            "affilname": "Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117011815",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Baiya Phytopharm Co. Ltd",
        "Chulalongkorn University Thailand",
        "DPST",
        "Chulalongkorn University"
    ]
}